Gynaecologic oncology specialists Prof. Nicoletta Colombo and Dr Natalia R Gómez-Hidalgo discuss three key clinical topics relating to PARP inhibitors in the first-line maintenance setting for advanced ovarian cancer
Watch now: [ Ссылка ]
--------------
This activity is funded by an independent medical education grant from GlaxoSmithKline. This activity is provided by touchIME.
